Interesting debate btw. I think the correlation between high levels of testing as relates to early identification is a big contributor to trend of increasing su

Interesting debate btw. I think the correlation between high levels of testing as relates to early identification is a big contributor to trend of increasing survival rates (along with advancing treatment options of course). Also important to note. MRIs are noninvasive. Biopsies, in BC cases, are fairly noninvasive. It’s typically just pulling out some cells with a needle, not to say it’s comfortable, but nothing to really fear either. So, I guess I just don’t see what the big deal is. Except it’s expensive. So, as is always the case with healthcare, the real debate should probably be about cost.